The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(8 sites)
China
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing Municipality The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Peking University Shenzhen Hospital, Shenzhen, Guangdong The Central Hospital Of WUHAN, Wuhan, Hubei Wuhan No.1 Hospital, Wuhan, Hubei The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Wuxi No.2 People's Hospital, Wuxi, Jiangsu Last updated September 2022